1,7-phenanthroline has been researched along with Cardiomyopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acton, S; Belagaje, R; Bloem, L; Dixon, J; Donaghue, M; Estridge, T; Jeyaseelan, R; Johnson, B; Kadambi, V; Matter, WF; Pickard, T; Stancato, L; Vlahos, CJ; Zhang, C | 1 |
1 other study(ies) available for 1,7-phenanthroline and Cardiomyopathies
Article | Year |
---|---|
Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.
Topics: Amino Acid Substitution; Angiotensin II; Calcium; Calcium Signaling; Cardiomyopathies; Cell Division; Cell Line; Chromatography, Affinity; Cloning, Molecular; Cytosol; Enzyme Inhibitors; Escherichia coli; Gene Library; Humans; Immediate-Early Proteins; Muscle, Skeletal; Mutagenesis, Site-Directed; Myocardium; Neoplasm Proteins; Organ Culture Techniques; Organometallic Compounds; Phenanthrolines; Protein Tyrosine Phosphatases; Recombinant Proteins; Signal Transduction; Transfection; Vanadates | 2001 |